[go: up one dir, main page]

GB9422836D0 - Monitoring malignant disease - Google Patents

Monitoring malignant disease

Info

Publication number
GB9422836D0
GB9422836D0 GB9422836A GB9422836A GB9422836D0 GB 9422836 D0 GB9422836 D0 GB 9422836D0 GB 9422836 A GB9422836 A GB 9422836A GB 9422836 A GB9422836 A GB 9422836A GB 9422836 D0 GB9422836 D0 GB 9422836D0
Authority
GB
United Kingdom
Prior art keywords
malignant disease
monitoring malignant
monitoring
disease
malignant
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
GB9422836A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Priority to GB9422836A priority Critical patent/GB9422836D0/en
Publication of GB9422836D0 publication Critical patent/GB9422836D0/en
Priority to PCT/GB1995/002647 priority patent/WO1996015263A1/en
Pending legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
    • C12Q1/6886—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material for cancer
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/112—Disease subtyping, staging or classification

Landscapes

  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Pathology (AREA)
  • Analytical Chemistry (AREA)
  • Zoology (AREA)
  • Genetics & Genomics (AREA)
  • Wood Science & Technology (AREA)
  • Physics & Mathematics (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • Molecular Biology (AREA)
  • Hospice & Palliative Care (AREA)
  • Biophysics (AREA)
  • Oncology (AREA)
  • Biochemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
GB9422836A 1994-11-11 1994-11-11 Monitoring malignant disease Pending GB9422836D0 (en)

Priority Applications (2)

Application Number Priority Date Filing Date Title
GB9422836A GB9422836D0 (en) 1994-11-11 1994-11-11 Monitoring malignant disease
PCT/GB1995/002647 WO1996015263A1 (en) 1994-11-11 1995-11-10 Monitoring malignant disease

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB9422836A GB9422836D0 (en) 1994-11-11 1994-11-11 Monitoring malignant disease

Publications (1)

Publication Number Publication Date
GB9422836D0 true GB9422836D0 (en) 1995-01-04

Family

ID=10764275

Family Applications (1)

Application Number Title Priority Date Filing Date
GB9422836A Pending GB9422836D0 (en) 1994-11-11 1994-11-11 Monitoring malignant disease

Country Status (2)

Country Link
GB (1) GB9422836D0 (en)
WO (1) WO1996015263A1 (en)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2253002A1 (en) * 1998-03-25 1999-09-25 Sabine Mai Method and marker for identification of premalignancy and malignancy and therapeutic intervention
CN100347316C (en) * 2005-02-04 2007-11-07 上海第二医科大学附属瑞金医院 AML-1 matator as one of leuckemia quick change major gene and its use
CN100453652C (en) * 2005-02-04 2009-01-21 上海第二医科大学附属瑞金医院 Method for detecting AML-1 mutant gene as one of leukaemia acute change major genes and its use
EP2557421A3 (en) * 2007-03-23 2013-06-05 King's College London Altered mitochondrial activity in diseases resulting from oxidative stress
US20150133450A1 (en) 2012-06-20 2015-05-14 Eutropics Pharmaceuticals, Inc. Methods and compositions useful for treating diseases involving bcl-2 family proteins with quinoline derivatives
EP2922544B1 (en) 2012-11-21 2018-08-01 Eutropics Pharmaceuticals, Inc. Methods and compositions useful for treating diseases involving bcl-2 family proteins with quinoline derivatives
US10732182B2 (en) 2013-08-01 2020-08-04 Eutropics Pharmaceuticals, Inc. Method for predicting cancer sensitivity
AU2014342269B2 (en) 2013-10-30 2020-02-27 Eutropics Pharmaceuticals, Inc. Methods for determining chemosensitivity and chemotoxicity
CA2974240A1 (en) 2015-01-12 2016-07-21 Eutropics Pharmaceuticals, Inc. Context dependent diagnostics test for guiding cancer treatment
US11242559B2 (en) 2015-01-13 2022-02-08 The Chinese University Of Hong Kong Method of nuclear DNA and mitochondrial DNA analysis
BR112017022666A8 (en) 2015-04-20 2022-10-18 Tolero Pharmaceuticals Inc PREPARING RESPONSE TO ALVOCIDIB BY MITOCHONDRIAL PROFILING
EP4086264B1 (en) 2015-05-18 2023-10-25 Sumitomo Pharma Oncology, Inc. Alvocidib prodrugs having increased bioavailability
CA2993659A1 (en) 2015-08-03 2017-02-09 Tolero Pharmaceuticals, Inc. Combination therapies for treatment of cancer
US11279694B2 (en) 2016-11-18 2022-03-22 Sumitomo Dainippon Pharma Oncology, Inc. Alvocidib prodrugs and their use as protein kinase inhibitors
KR20190099260A (en) 2016-12-19 2019-08-26 톨레로 파마수티컬스, 인크. Profiling Peptides and Methods for Sensitivity Profiling
JP7196160B2 (en) 2017-09-12 2022-12-26 スミトモ ファーマ オンコロジー， インコーポレイテッド Treatment Regimens for Cancers Insensitive to BCL-2 Inhibitors Using the MCL-1 Inhibitor Albocidib
CA3119807A1 (en) 2018-12-04 2020-06-11 Sumitomo Dainippon Pharma Oncology, Inc. Cdk9 inhibitors and polymorphs thereof for use as agents for treatment of cancer
US11793802B2 (en) 2019-03-20 2023-10-24 Sumitomo Pharma Oncology, Inc. Treatment of acute myeloid leukemia (AML) with venetoclax failure

Also Published As

Publication number Publication date
WO1996015263A1 (en) 1996-05-23

Similar Documents

Publication Publication Date Title
EP0694307A4 (en) Atopic disease remedy
EP0706781A3 (en) Morcellator
GB9422836D0 (en) Monitoring malignant disease
GB2325519B (en) Physiological movement monitoring
DE69517588D1 (en) Gekühlter transportcontainer
AU122938S (en) Breadbox
ZA958215B (en) Microbicides
SK5595A3 (en) Built-in mechanizm
GB2295534B (en) Scraper
PL312691A1 (en) New substituted benzyimidazole
GB2331742A9 (en) Monitoring
SG69962A1 (en) Indan
CA75064S (en) Drum
PL302688A1 (en) Blast-hole wadding
GB9419382D0 (en) Monitoring methods
PL56634Y1 (en) Strainer
PL56068Y1 (en) Bedside table-cabinet
GB9422322D0 (en) Electroencephalograph
GB9621885D0 (en) Diagnosis
GB9621469D0 (en) Diagnosis
PL100757U1 (en) Purse
AU122067S (en) Shopfitting unit
GB9409155D0 (en) Draught - excluding unit
ZA953542B (en) Microbicides
GB9420238D0 (en) Boundary monitor